Yan Zhou

Title: Yan Zhou: Innovator in Pharmaceutical Compositions

Introduction

Yan Zhou is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for cancer treatment. With a total of 2 patents, her work is paving the way for advancements in therapeutic options.

Latest Patents

Yan Zhou's latest patents include groundbreaking pharmaceutical compositions. The first patent focuses on a human PD-1 antibody, known as retifanlimab, which is designed for storage and administration. This composition includes buffering agents and is intended for use in treating cancers that express PD-L1. The second patent involves a HER2/neu antibody, margetuximab, which is stable and also includes buffering agents and stabilizers. This invention aims to treat HER2/neu-positive cancers, including breast, gastric, and GEJ cancers.

Career Highlights

Yan Zhou is currently employed at Macrogenics, Inc., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving cancer treatment options through her patented compositions.

Collaborations

Yan Zhou collaborates with notable colleagues, including Krishnan Sampathkumar and David Lee Farb. These partnerships enhance her research and development efforts, contributing to the success of her projects.

Conclusion

In summary, Yan Zhou is a dedicated inventor whose work in pharmaceutical compositions is making a significant impact in cancer treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science.